Literature DB >> 17462788

The association between hospitalisation for pneumonia and the diagnosis of lung cancer.

Vidar Søyseth1, Jūrate Saltyte Benth, Knut Stavem.   

Abstract

Pneumonia may mask or be the first sign of lung cancer. The literature is, however, sparse. We compared the incidence of lung cancer among patients hospitalised for pneumonia with a general population. The patients (index group, N=7044) were hospitalised for pneumonia from 1988 to 2002 at Akershus University Hospital. The reference group was recruited from a general population survey (N=81,373) performed during 1984-1986 and 1995-1997. We had detailed information on smoking habits in both groups. Data on lung cancer incidence, emigration, and death were obtained from the Cancer Registry of Norway. Data were analyzed using multivariate Poisson regression. There were 177 cases of lung cancer in the index group and 608 cases in the reference group. Current smoking modified the association between pneumonia and lung cancer. Among current smokers and non-smokers the incidence density ratio (IDR) was 6.0 (95% confidence interval) (4.6-7.8) and 12.0 (8.6-16.9) in the index group compared with the references, respectively. The crude IDR decreased from 78.4 (43.8-146) 0-3 months after the inclusion to 2.4 (1.4-3.7) 6 years after inclusion. In the index group the IDR was only slightly higher for smokers than non-smokers. Patients hospitalised for pneumonia had an increased incidence of lung cancer compared with the general population. This risk persisted for 6 years after the onset of the lung infection.

Entities:  

Mesh:

Year:  2007        PMID: 17462788     DOI: 10.1016/j.lungcan.2007.02.022

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  6 in total

1.  Improving Detection Accuracy of Lung Cancer Serum Proteomic Profiling via Two-Stage Training Process.

Authors:  Pei-Sung Hsu; Yu-Shan Wang; Su-Chen Huang; Yi-Hsien Lin; Chih-Chia Chang; Yuk-Wah Tsang; Jiunn-Song Jiang; Shang-Jyh Kao; Wu-Ching Uen; Kwan-Hwa Chi
Journal:  Proteome Sci       Date:  2011-04-17       Impact factor: 2.480

2.  Efficacy and safety of 3 mg pegylated recombinant human granulocyte colony-stimulating factor as support to chemotherapy for lung cancer.

Authors:  Xiang Ji; Lisheng Xu; Pengfei Pan; Zhiyun Xu; Aihua Wang; Yu Li
Journal:  Thorac Cancer       Date:  2021-11-17       Impact factor: 3.500

3.  Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients.

Authors:  Baykal Tulek; Habibe Koylu; Fikret Kanat; Ugur Arslan; Faruk Ozer
Journal:  Contemp Oncol (Pozn)       Date:  2013-03-15

4.  The effects of radiation and dose-fractionation on cancer and non-tumor disease development.

Authors:  William Liu; Benjamin M Haley; Mary J Kwasny; Jian-Jian Li; David J Grdina; Tatjana Paunesku; Gayle E Woloschak
Journal:  Int J Environ Res Public Health       Date:  2012-12-18       Impact factor: 3.390

5.  Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer patients with malignant pleural effusions.

Authors:  Do-Sim Park; Dong Kim; Ki-Eun Hwang; Yu-Ri Hwang; Chul Park; Chang-Hwan Seol; Kyung-Hwa Cho; Byoung-Ryun Kim; Seong-Hoon Park; Eun-Taik Jeong; Hak-Ryul Kim
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

Review 6.  Post-Obstructive Pneumonia in Patients with Cancer: A Review.

Authors:  Kenneth V I Rolston; Lior Nesher
Journal:  Infect Dis Ther       Date:  2018-02-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.